Newsletter SignupSearch

Parachuting with Purpose: Local US Marine Corps Veteran BASE Jumps Off Camelback Mountain to Raise Awareness of Veteran Suicide

Suicide is the second leading cause of death among post-9/11 Veterans. Marine Veteran and Arizona State University alumni Tristan Wimmer is returning to the skies of his hometown to bring attention to this national crisis.
Meet Magali Haas, MD, PhD, President and CEO of Cohen Veterans Bioscience (CVB), a leader in the development of cutting-edge testing and therapeutics for traumatic brain injuries

Suicide is the second leading cause of death among post-9/11 Veterans. Marine Veteran and Arizona State University alumni Tristan Wimmer is returning to the skies of his hometown to bring attention to this national crisis.

On Jan. 29, 2022, Wimmer will team up with four other Veterans to complete 22 BASE jumps off of Camelback Mountain 22 is symbolic of the 22 United States Active Duty and Veterans who succumb to suicide each day. The jumps will be held as part of the 3rd Annual 22 Jumps event at Camelback Mountain in Phoenix, AZ, beginning 6 a.m. (MST).

After exceeding his symbolic $22,000 fundraising goal last year, Wimmer and his team hope to raise another $22,000 for 2022. Donations can also be made online via the 22 Jumps website or on Facebook.

Wimmer’s brother took his own life in 2015 after sustaining a traumatic brain injury (TBI) in Iraq while serving in the United States Marine Corps. The event, 22 Jumps, began in 2020 as a tribute to his brother, but quickly drew local and national media attention, as well as support from the brain injury, mental health, and Veterans’ communities, and countless families affected by Veteran suicide. Since then, Wimmer’s effort, has been awarded nonprofit status and has grown into a nationwide initiative with more than $100,000 raised across several events. All funds raised go to support Cohen Veteran Bioscience (CVB), a nonprofit biomedical research organization that is dedicated to fast-tracking precision diagnostics and tailored therapeutics for brain trauma, a major risk factor for suicide.

22 Jumps founder and veteran Tristan Wimmer stated, “TBIs disproportionately effect servicemen and women. I personally know dozens of Veterans suffering from post-traumatic stress disorder (PTSD) and emotional management issues‚ many of whom have succumb to suicide. The effects of those deployments linger long after returning home. I’m honored to fundraise for CVB, an organization that recognizes the need to develop new treatment options for the millions of Veterans and civilians who suffer from TBIs and other mental health issues to finally combat the epidemic of Veterans suicide. To move forward, Veterans need more advocates like CVB, and we need more science that embraces the complexity of this Veteran-heavy disease.”

Fast Facts about TBI and Veteran Suicide

TBI Fast Fact


19% of Iraq and Afghanistan Veterans reported a probable TBI during deployment.

Veteran Suicide Fast Fact


Veteran suicides make up a disproportionate 14% of total suicides in America.

Fast Fact

2.7 Million

TBI and PTSD have taken an enormous toll on Veteran populations with more than 2.7 million men and women deployed to support combat operations in Iraq and Afghanistan since 2001.

Fast Fact

Under 50%

Less than 50% of all veterans in need receive any type of mental health diagnosis or treatment.

Learn More about 22 Jumps

22 Jumps

22 Jumps aims to bring new hope to individuals and families affected by TBI and suicide.
Due to a lack of objective diagnostic tools and effective treatment solutions, the “invisible wounds” of traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) often leave service members and civilians feeling hopeless as they live with multiple debilitating symptoms and few treatment options.

If you or someone you know is having thoughts of suicide, contact the Veterans Crisis Line at 1-800-273-8255 to receive free, confidential support and crisis interventional available 24/7/365.

Share this article:

More from CVB

American Brain Coalition Selects Cohen Veterans Bioscience Executive as New Board Member

New Artificial-Intelligence-based Tools for Monitoring Parkinson’s Disease using Wearable Devices

Peter Hoehn, Accomplished Pharmaceutical Executive, Joins Cohen Veterans Bioscience (CVB) in Newly Created Executive Leadership Role

About Cohen Veterans Bioscience (CVB)

Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.